Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

It comes as Health Secretary Robert F. Kennedy Jr. and his appointees continue to scrutinize the use of vaccines for a number ...

The approach -- using a placebo when a "standard-of-care" vaccine already exists -- is contentious within the biomedical ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID-19 vaccine boosters.

BRUSSELS - The World Health Organization's member states on Tuesday adopted a landmark Pandemic Agreement on tackling future ...

The World Health Organization's member countries on Tuesday approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the ...